Plain-English translation of NCT07226934 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lymphoma research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether artificial intelligence can help patients with blood cancers like lymphoma and multiple myeloma ask better questions during their doctor appointments. Researchers will use a secure, hospital-based AI tool to create personalized question lists based on each patient's specific situation and concerns. The goal is to see if these suggested questions help patients feel more confident communicating with their doctors and getting the information they need about their disease and treatment.
Many cancer patients don't get to ask all the questions they have during appointments, which can leave them feeling uncertain about their treatment and care. This study explores whether an AI-generated personalized question list can help patients feel more prepared and empowered to have better conversations with their doctors.
You likely qualify if…
You likely don't qualify if…
You will complete a short survey before your first appointment, then receive a personalized list of questions generated by the hospital's AI tool based on your medical situation. You can use these questions during your next scheduled cancer clinic appointment if you find them helpful. After your appointment, you'll complete another survey to share your thoughts about the question list, whether it was easy to use, and whether you'd consider using similar tools in the future.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States